Lirio empowers you to orchestrate each person’s unique and evolving healthcare journey using hyper-personalized communications that support health outcomes.
The Lirio platform influences each person’s health actions by leveraging behavioral science expertise and adapting to people’s evolving clinical history and social context.
Powered by the world’s first Large Behavior Model for healthcare, it allows you to automate the ways you engage with your population via dynamic, personalized communications that create individualized healthcare experiences.
We call it Precision Nudging®
And whether it’s helping patients or members enroll, engage, or navigate, Lirio helps you close gaps in care and work to ensure every person’s journey is marked by autonomy, empowerment, and improved outcomes.
One-to-One Personalization
We move past standard demographic segmentation to create highly tailored communications that make individuals feel known.
Sustained Engagement
Our platform continuously learns, and our behavioral interventions adapt in real time to help you motivate patients and members to stay engaged with their health and your organization.
Healthier Populations
Lirio helps you reach more people earlier with the right care solutions so you can guide them on their unique, ongoing health journeys, address health equity issues, and close gaps in care.
Lower Total Cost of Care
We automate many of the ongoing touchpoints with your population so you can maintain engagement at scale while strategically allocating limited resources.
How Lirio Moves People
Discover Lirio
Health Systems
Move patients toward relational engagement that supports improved population outcomes.
Payers
Move members to engage with benefits that lead to better outcomes and lower costs.
5 plans of attack: How payers can succeed facing new CMS rules in 2025 – and beyond
The FDA’s approval of a nasal mist flu vaccine for at-home use represents more than just a convenient alternative to the traditional flu shot — it marks a significant shift in healthcare delivery, moving toward a decentralized model where patients can self-administer care from the comfort of their own homes.
The new nasal flu mist vaccine ushers in a new era of at-home healthcare
The FDA’s approval of a nasal mist flu vaccine for at-home use represents more than just a convenient alternative to the traditional flu shot — it marks a significant shift in healthcare delivery, moving toward a decentralized model where patients can self-administer care from the comfort of their own homes.
Why good design is a crucial in any health equity strategy
Furniture and clothing are two obvious examples of why a “one-size-fits-all" design approach...
Lirio partners with Vanderbilt Medical Center to transform healthcare chatbots – and patient trust in them
Patients checking their symptoms.Payers answering questions about plan coverage.Providers...
How It Works
Want to see our process in action? Learn more about our approach that moves people along their unique journeys to better health.